US Stock MarketDetailed Quotes

Trevi Therapeutics (TRVI)

Watchlist
  • 15.230
  • +0.690+4.75%
Close Apr 17 16:00 ET
  • 15.246
  • +0.016+0.10%
Post 20:01 ET
1.96BMarket Cap-47.59P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Trevi Therapeutics (TRVI) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-4.26%49.33M
-16.52%10.22M
-1.21%13.92M
3.26%13.72M
-3.66%11.47M
51.89%51.52M
37.05%12.24M
55.74%14.09M
58.54%13.29M
57.42%11.91M
Selling and administrative expenses
30.48%15.85M
38.15%4.03M
33.81%3.83M
32.59%4.33M
17.96%3.66M
18.62%12.15M
20.70%2.92M
5.18%2.86M
28.66%3.27M
21.03%3.1M
-General and administrative expense
30.48%15.85M
38.15%4.03M
33.81%3.83M
32.59%4.33M
17.96%3.66M
18.62%12.15M
20.70%2.92M
5.18%2.86M
28.66%3.27M
21.03%3.1M
Research and development costs
-14.98%33.48M
-33.61%6.19M
-10.15%10.09M
-6.31%9.39M
-11.28%7.81M
66.27%39.38M
43.11%9.33M
77.51%11.22M
71.53%10.02M
76.08%8.8M
Operating profit
4.26%-49.33M
16.52%-10.22M
1.21%-13.92M
-3.26%-13.72M
3.66%-11.47M
-51.89%-51.52M
-37.05%-12.24M
-55.74%-14.09M
-58.54%-13.29M
-57.42%-11.91M
Net non-operating interest income expense
81.66%6.54M
126.01%1.9M
154.67%2.1M
50.64%1.41M
12.84%1.13M
-17.42%3.6M
-25.68%842K
-30.08%825K
-11.39%934K
0.71%997K
Non-operating interest income
81.45%6.54M
125.74%1.9M
154.36%2.1M
50.48%1.41M
12.73%1.13M
-24.14%3.6M
-25.86%843K
-30.18%826K
-22.54%935K
-18.26%998K
Non-operating interest expense
--0
--0
--0
--0
--0
-98.98%4K
-75.00%1K
-66.67%1K
-99.35%1K
-99.57%1K
Other net income (expense)
-106.67%-31K
-850.00%-15K
81.82%-2K
-40.00%-7K
-500.00%-6K
-103.20%-15K
166.67%2K
-107.14%-11K
-103.27%-5K
-100.61%-1K
Other non- operating income (expenses)
-106.67%-31K
-850.00%-15K
81.82%-2K
-40.00%-7K
-500.00%-6K
-103.20%-15K
166.67%2K
-107.14%-11K
-103.27%-5K
-100.61%-1K
Income before tax
10.68%-42.82M
26.91%-8.33M
10.97%-11.82M
0.31%-12.32M
5.12%-10.35M
-64.76%-47.94M
-46.08%-11.4M
-72.13%-13.27M
-72.26%-12.36M
-70.26%-10.91M
Income tax
-113.33%-64K
-200.00%-16K
51.61%-15K
-162.50%-21K
-37.50%-11K
6.25%-30K
-11.11%16K
-138.46%-31K
73.33%-8K
-14.29%-8K
Net income
10.75%-42.76M
27.15%-8.32M
10.87%-11.8M
0.41%-12.3M
5.16%-10.34M
-64.84%-47.91M
-45.95%-11.42M
-72.02%-13.24M
-72.88%-12.35M
-70.32%-10.9M
Net income continuous Operations
10.75%-42.76M
27.15%-8.32M
10.87%-11.8M
0.41%-12.3M
5.16%-10.34M
-64.84%-47.91M
-45.95%-11.42M
-72.02%-13.24M
-72.88%-12.35M
-70.32%-10.9M
Minority interest income
Net income attributable to the parent company
10.75%-42.76M
27.15%-8.32M
10.87%-11.8M
0.41%-12.3M
5.16%-10.34M
-64.84%-47.91M
-45.95%-11.42M
-72.02%-13.24M
-72.88%-12.35M
-70.32%-10.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
10.75%-42.76M
27.15%-8.32M
10.87%-11.8M
0.41%-12.3M
5.16%-10.34M
-64.84%-47.91M
-45.95%-11.42M
-72.02%-13.24M
-72.88%-12.35M
-70.32%-10.9M
Basic earnings per share
31.91%-0.32
45.45%-0.06
38.46%-0.08
25.00%-0.09
18.18%-0.09
-62.07%-0.47
-37.50%-0.11
-62.50%-0.13
-71.43%-0.12
-83.33%-0.11
Diluted earnings per share
31.91%-0.32
45.45%-0.06
38.46%-0.08
25.00%-0.09
18.18%-0.09
-62.07%-0.47
-37.50%-0.11
-62.50%-0.13
-71.43%-0.12
-83.33%-0.11
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -4.26%49.33M-16.52%10.22M-1.21%13.92M3.26%13.72M-3.66%11.47M51.89%51.52M37.05%12.24M55.74%14.09M58.54%13.29M57.42%11.91M
Selling and administrative expenses 30.48%15.85M38.15%4.03M33.81%3.83M32.59%4.33M17.96%3.66M18.62%12.15M20.70%2.92M5.18%2.86M28.66%3.27M21.03%3.1M
-General and administrative expense 30.48%15.85M38.15%4.03M33.81%3.83M32.59%4.33M17.96%3.66M18.62%12.15M20.70%2.92M5.18%2.86M28.66%3.27M21.03%3.1M
Research and development costs -14.98%33.48M-33.61%6.19M-10.15%10.09M-6.31%9.39M-11.28%7.81M66.27%39.38M43.11%9.33M77.51%11.22M71.53%10.02M76.08%8.8M
Operating profit 4.26%-49.33M16.52%-10.22M1.21%-13.92M-3.26%-13.72M3.66%-11.47M-51.89%-51.52M-37.05%-12.24M-55.74%-14.09M-58.54%-13.29M-57.42%-11.91M
Net non-operating interest income expense 81.66%6.54M126.01%1.9M154.67%2.1M50.64%1.41M12.84%1.13M-17.42%3.6M-25.68%842K-30.08%825K-11.39%934K0.71%997K
Non-operating interest income 81.45%6.54M125.74%1.9M154.36%2.1M50.48%1.41M12.73%1.13M-24.14%3.6M-25.86%843K-30.18%826K-22.54%935K-18.26%998K
Non-operating interest expense --0--0--0--0--0-98.98%4K-75.00%1K-66.67%1K-99.35%1K-99.57%1K
Other net income (expense) -106.67%-31K-850.00%-15K81.82%-2K-40.00%-7K-500.00%-6K-103.20%-15K166.67%2K-107.14%-11K-103.27%-5K-100.61%-1K
Other non- operating income (expenses) -106.67%-31K-850.00%-15K81.82%-2K-40.00%-7K-500.00%-6K-103.20%-15K166.67%2K-107.14%-11K-103.27%-5K-100.61%-1K
Income before tax 10.68%-42.82M26.91%-8.33M10.97%-11.82M0.31%-12.32M5.12%-10.35M-64.76%-47.94M-46.08%-11.4M-72.13%-13.27M-72.26%-12.36M-70.26%-10.91M
Income tax -113.33%-64K-200.00%-16K51.61%-15K-162.50%-21K-37.50%-11K6.25%-30K-11.11%16K-138.46%-31K73.33%-8K-14.29%-8K
Net income 10.75%-42.76M27.15%-8.32M10.87%-11.8M0.41%-12.3M5.16%-10.34M-64.84%-47.91M-45.95%-11.42M-72.02%-13.24M-72.88%-12.35M-70.32%-10.9M
Net income continuous Operations 10.75%-42.76M27.15%-8.32M10.87%-11.8M0.41%-12.3M5.16%-10.34M-64.84%-47.91M-45.95%-11.42M-72.02%-13.24M-72.88%-12.35M-70.32%-10.9M
Minority interest income
Net income attributable to the parent company 10.75%-42.76M27.15%-8.32M10.87%-11.8M0.41%-12.3M5.16%-10.34M-64.84%-47.91M-45.95%-11.42M-72.02%-13.24M-72.88%-12.35M-70.32%-10.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 10.75%-42.76M27.15%-8.32M10.87%-11.8M0.41%-12.3M5.16%-10.34M-64.84%-47.91M-45.95%-11.42M-72.02%-13.24M-72.88%-12.35M-70.32%-10.9M
Basic earnings per share 31.91%-0.3245.45%-0.0638.46%-0.0825.00%-0.0918.18%-0.09-62.07%-0.47-37.50%-0.11-62.50%-0.13-71.43%-0.12-83.33%-0.11
Diluted earnings per share 31.91%-0.3245.45%-0.0638.46%-0.0825.00%-0.0918.18%-0.09-62.07%-0.47-37.50%-0.11-62.50%-0.13-71.43%-0.12-83.33%-0.11
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -